Comprehensive Analysis of DNA Methylation and Gene Expression Profiles in Cholangiocarcinoma

Overview

Journal Cancer Cell Int

Publisher Biomed Central

Date 2020 Jan 1

PMID 31889904

Citations 16

Authors

Cheng Zhang

Bingye Zhang

Di Meng

Chunlin Ge

Affiliations

Soon will be listed here.

Abstract

Background: The incidence of cholangiocarcinoma (CCA) has risen in recent years, and it has become a significant health burden worldwide. However, the mechanisms underlying tumorigenesis and progression of this disease remain largely unknown. An increasing number of studies have demonstrated crucial biological functions of epigenetic modifications, especially DNA methylation, in CCA. The present study aimed to identify and analyze methylation-regulated differentially expressed genes (MeDEGs) involved in CCA tumorigenesis and progression by bioinformatics analysis.

Methods: The gene expression profiling dataset (GSE119336) and gene methylation profiling dataset (GSE38860) were obtained from the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) and differentially methylated genes (DMGs) were identified using the limma packages of R and GEO2R, respectively. The MeDEGs were obtained by overlapping the DEGs and DMGs. Functional enrichment analyses of these genes were then carried out. Protein-protein interaction (PPI) networks were constructed using STRING and visualized in Cytoscape to determine hub genes. Finally, the results were verified based on The Cancer Genome Atlas (TCGA) database.

Results: We identified 98 hypermethylated, downregulated genes and 93 hypomethylated, upregulated genes after overlapping the DEGs and DMGs. These genes were mainly enriched in the biological processes of the cell cycle, nuclear division, xenobiotic metabolism, drug catabolism, and negative regulation of proteolysis. The top nine hub genes of the PPI network were F2, AHSG, RRM2, AURKB, CCNA2, TOP2A, BIRC5, PLK1, and ASPM. Moreover, the expression and methylation status of the hub genes were significantly altered in TCGA.

Conclusions: Our study identified novel methylation-regulated differentially expressed genes (MeDEGs) and explored their related pathways and functions in CCA, which may provide novel insights into a further understanding of methylation-mediated regulatory mechanisms in CCA.

Citing Articles

Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives.

Wang Y, Zhang M, Xu J, Zheng L, Liu P, Chen J MedComm (2020). 2024; 5(9):e670.

PMID: 39184862 PMC: 11344282. DOI: 10.1002/mco2.670.

Bioinformatics and system biology approaches to determine the connection of SARS-CoV-2 infection and intrahepatic cholangiocarcinoma.

Zhou X, Huang T, Pan H, Du A, Wu T, Lan J PLoS One. 2024; 19(4):e0300441.

PMID: 38648205 PMC: 11034673. DOI: 10.1371/journal.pone.0300441.

Construction of lncRNA- and circRNA-associated ceRNA networks in the prostatic urethra of rats after simulating transurethral laser prostatectomy (TULP).

Tang X, Liu Z, Liu H, Zhang H, Tian Y, Xia S Mol Cell Biochem. 2023; 479(6):1363-1377.

PMID: 37410211 PMC: 11224087. DOI: 10.1007/s11010-023-04804-1.

Oncogenic ASPM Is a Regulatory Hub of Developmental and Stemness Signaling in Cancers.

Tsai K, Bae B, Hsu C, Cheng L, Shaked Y Cancer Res. 2023; 83(18):2993-3000.

PMID: 37384617 PMC: 10502471. DOI: 10.1158/0008-5472.CAN-23-0158.

RNA-sequencing reveals the expression profiles of tsRNAs and their potential carcinogenic role in cholangiocarcinoma.

Li Y, Yan L, Wang A, Jiang L, Xu Q, Wang B J Clin Lab Anal. 2022; 36(10):e24694.

PMID: 36098712 PMC: 9550958. DOI: 10.1002/jcla.24694.

References

Lang F, Sun Z, Pei Y, Singh R, Jha H, Robertson E . Correction: Shugoshin 1 is dislocated by KSHV-encoded LANA inducing aneuploidy. PLoS Pathog. 2019; 15(4):e1007732. PMC: 6456169. DOI: 10.1371/journal.ppat.1007732. View

Sohail M, Schmid D, Wlcek K, Spork M, Szakacs G, Trauner M . Molecular Mechanism of Taurocholate Transport by the Bile Salt Export Pump, an ABC Transporter Associated with Intrahepatic Cholestasis. Mol Pharmacol. 2017; 92(4):401-413. PMC: 7610612. DOI: 10.1124/mol.117.108688. View

Hsu C, Liao W, Chan T, Chen W, Lee C, Shan Y . The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis. J Pathol. 2019; 249(4):498-508. PMC: 6899738. DOI: 10.1002/path.5341. View

Rahane C, Kutzner A, Heese K . A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature. J Neurooncol. 2018; 141(1):57-70. DOI: 10.1007/s11060-018-03029-3. View

Wang N, Zhang C, Wang W, Liu J, Yu Y, Li Y . Long noncoding RNA DANCR regulates proliferation and migration by epigenetically silencing FBP1 in tumorigenesis of cholangiocarcinoma. Cell Death Dis. 2019; 10(8):585. PMC: 6683119. DOI: 10.1038/s41419-019-1810-z. View

Guo L, Mohd K, Ren H, Xin G, Jiang Q, Clarke P . Phosphorylation of importin-α1 by CDK1-cyclin B1 controls mitotic spindle assembly. J Cell Sci. 2019; 132(18). PMC: 6765185. DOI: 10.1242/jcs.232314. View

Stark R, Grzelak M, Hadfield J . RNA sequencing: the teenage years. Nat Rev Genet. 2019; 20(11):631-656. DOI: 10.1038/s41576-019-0150-2. View

Moore L, Le T, Fan G . DNA methylation and its basic function. Neuropsychopharmacology. 2012; 38(1):23-38. PMC: 3521964. DOI: 10.1038/npp.2012.112. View

Koch A, Jeschke J, Van Criekinge W, van Engeland M, De Meyer T . MEXPRESS update 2019. Nucleic Acids Res. 2019; 47(W1):W561-W565. PMC: 6602516. DOI: 10.1093/nar/gkz445. View

10.

Liu P, Zhou T, Qiu B, Yang Y, Zhu Y, An Y . Methylation-Mediated Silencing of GATA5 Gene Suppresses Cholangiocarcinoma Cell Proliferation and Metastasis. Transl Oncol. 2018; 11(3):585-592. PMC: 5854920. DOI: 10.1016/j.tranon.2018.01.023. View

11.

Seborova K, Vaclavikova R, Soucek P, Elsnerova K, Bartakova A, cernaj P . Association of ABC gene profiles with time to progression and resistance in ovarian cancer revealed by bioinformatics analyses. Cancer Med. 2019; 8(2):606-616. PMC: 6382717. DOI: 10.1002/cam4.1964. View

12.

Tong Y, Song Y, Deng S . Combined analysis and validation for DNA methylation and gene expression profiles associated with prostate cancer. Cancer Cell Int. 2019; 19:50. PMC: 6399908. DOI: 10.1186/s12935-019-0753-x. View

13.

Razumilava N, Gores G . Cholangiocarcinoma. Lancet. 2014; 383(9935):2168-79. PMC: 4069226. DOI: 10.1016/S0140-6736(13)61903-0. View

14.

Bagante F, Spolverato G, Merath K, Weiss M, Alexandrescu S, Marques H . Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection. Surgery. 2019; 166(6):983-990. DOI: 10.1016/j.surg.2019.06.005. View

15.

Zhang C, Ge C . A Simple Competing Endogenous RNA Network Identifies Novel mRNA, miRNA, and lncRNA Markers in Human Cholangiocarcinoma. Biomed Res Int. 2019; 2019:3526407. PMC: 6451803. DOI: 10.1155/2019/3526407. View

16.

Manikandan P, Nagini S . Cytochrome P450 Structure, Function and Clinical Significance: A Review. Curr Drug Targets. 2017; 19(1):38-54. DOI: 10.2174/1389450118666170125144557. View

17.

Sumsakul W, Mahavorasirikul W, Na-Bangchang K . Inhibitory Activities of Thai Medicinal Plants with Promising Activities Against Malaria and Cholangiocarcinoma on Human Cytochrome P450. Phytother Res. 2015; 29(12):1926-33. DOI: 10.1002/ptr.5485. View

18.

Shen Y, Hu F, Jeng Y, Chang Y, Lin Z, Chang M . Nuclear overexpression of mitotic regulatory proteins in biliary tract cancer: correlation with clinicopathologic features and patient survival. Cancer Epidemiol Biomarkers Prev. 2009; 18(2):417-23. DOI: 10.1158/1055-9965.EPI-08-0691. View

19.

Belkouz A, Labeur T, Dierks J, Dijk F, van Oijen M, Verheij J . Prognostic immunohistochemical biomarkers of chemotherapy efficacy in biliary tract cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2019; 141:82-94. DOI: 10.1016/j.critrevonc.2019.06.001. View

20.

Pang Q, Zhou L, Hu X, Wang Y, Man Z, Yang S . Biliary stenting alone versus biliary stenting combined with I particles intracavitary irradiation for the treatment of advanced cholangiocarcinoma. Sci Rep. 2019; 9(1):11348. PMC: 6683155. DOI: 10.1038/s41598-019-47791-4. View